VEGFA and cancer: The 2016 European Society of Cardiology position paper on cancer treatments and cardiovascular toxicity mainly focuses on RT and three categories of anticancer drugs, namely antimetabolites, platinum compounds, and vascular endothelial growth factor pathway inhibitors, as the most important toxic agents for the coronary arteries [5].